Treatment of Nasal Cellulitis
For nasal cellulitis, initiate oral antibiotics active against streptococci and MSSA (such as cephalexin 500 mg four times daily or dicloxacillin) for 5 days, with MRSA coverage (vancomycin IV or clindamycin oral) reserved only for patients with purulent drainage, penetrating trauma, known MRSA colonization, or systemic toxicity. 1
Antibiotic Selection Based on Severity
Mild Cases (Outpatient Management)
- First-line oral antibiotics for typical non-purulent nasal cellulitis should target streptococci, the most common causative organisms 1, 2
- Recommended oral regimens include:
Moderate to Severe Cases (Consider Hospitalization)
- Intravenous antibiotics are indicated when systemic signs are present (fever >38.5°C, heart rate >110, WBC >12,000, or SIRS criteria) 1, 3
- For severe infections without MRSA risk factors, use cefazolin 1 g every 8 hours IV 1
- For severe infections with MRSA risk factors (penetrating trauma, known MRSA colonization, injection drug use, purulent drainage), use vancomycin 15 mg/kg every 12 hours IV 1
- In severely compromised or immunocompromised patients, consider broad-spectrum coverage with vancomycin plus piperacillin-tazobactam or imipenem/meropenem 1
MRSA Coverage: When to Add It
MRSA is an unusual cause of typical cellulitis and routine coverage is not necessary 2, 3. Add MRSA-active antibiotics only when specific risk factors are present:
- Purulent drainage from the nasal area 1, 2
- Penetrating trauma to the nose 1
- Known MRSA colonization or infection elsewhere 1
- Injection drug use history 1
- Systemic inflammatory response syndrome (SIRS) 1
Treatment Duration
- Treat for 5 days if clinical improvement occurs 1, 2, 3
- Extend treatment only if the infection has not improved within this initial 5-day period 1, 2
- This shorter duration is as effective as traditional 10-day courses for uncomplicated cellulitis 2
Hospitalization Criteria
Outpatient therapy is appropriate for most patients without systemic toxicity 1. Hospitalize if any of the following are present:
- SIRS criteria, altered mental status, or hemodynamic instability 1, 3
- Concern for deeper or necrotizing infection 1
- Severe immunocompromise 1
- Poor adherence to outpatient therapy 1
- Failure of outpatient treatment 1
Adjunctive Measures
- Elevation of the affected area promotes drainage and hastens improvement 1, 4, 2
- Identify and treat predisposing factors such as nasal vestibulitis, chronic rhinosinusitis, nasal trauma, or underlying dermatologic conditions 1, 3
- Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adults to reduce inflammation 1, 2
- Intranasal decongestants and corticosteroids may reduce progression to complications if sinusitis is contributing 5
Special Considerations for Periorbital Extension
If nasal cellulitis extends to periorbital tissues (a serious complication):
- Ceftriaxone 1-2 g IV daily plus metronidazole 500 mg every 8 hours is associated with shorter hospital stays and reduced need for surgical intervention compared to ceftriaxone alone or co-amoxiclav 5
- Urgent ophthalmology and ENT consultation is mandatory 5
- CT imaging should be obtained to assess for orbital involvement or abscess formation 5, 6
Common Pitfalls to Avoid
- Don't routinely obtain blood cultures or tissue aspirates in typical cases—diagnosis is clinical 1, 3
- Don't automatically add MRSA coverage without specific risk factors; this leads to unnecessary broad-spectrum antibiotic use 2, 3
- Don't extend treatment beyond 5 days if clinical improvement has occurred 1, 2
- Don't use standard antibiotic dosing in patients with severe renal impairment (GFR <15 mL/min)—clindamycin requires no adjustment, but most other agents need dose reduction 4
Prevention of Recurrence
For patients with recurrent nasal cellulitis (3-4 episodes per year):
- Prophylactic antibiotics such as oral penicillin or erythromycin twice daily for 4-52 weeks, or intramuscular benzathine penicillin every 2-4 weeks 1, 3
- Continue prophylaxis as long as predisposing factors persist 1
- Address underlying conditions such as chronic rhinosinusitis, nasal vestibulitis, or immunodeficiency 1, 3, 6